Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
21,207,917
-
Share change
-
+3,781,730
-
Total reported value
-
$6,435,768,089
-
Put/Call ratio
-
169%
-
Price per share
-
$303.33
-
Number of holders
-
408
-
Value change
-
+$1,103,919,618
-
Number of buys
-
195
-
Number of sells
-
195
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q3 2015
As of 30 Sep 2015,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
408 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,207,917 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, CITIGROUP INC, BNP PARIBAS ARBITRAGE, SA, CREDIT SUISSE AG/, JPMORGAN CHASE & CO, UBS Group AG, SG Americas Securities, LLC, and ASSETMARK, INC.
This page lists
408
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.